首页> 外文会议>Optogenetics and Optical Manipulation >Multi-Characteristic Opsin enabled Vision Restoration
【24h】

Multi-Characteristic Opsin enabled Vision Restoration

机译:支持多特征视蛋白的视觉恢复

获取原文
获取原文并翻译 | 示例

摘要

Photodegenerative retinal diseases such as retinitis pigmentosa (RP) and dry age related macular degeneration (dry-AMD) lead to loss of vision in millions of individuals. Currently, no surgical or medical treatment is available though optogenetic therapies are in clinical development. Here, we demonstrate vision restoration using Multi-Characteristics Opsin (MCO1) in animal models with photo-degenerated retina. MCO1 is reliably delivered to specific retinal cells via intravitreal injection of Adeno-Associated Virus, leading to significant improvement in visually guided behavior conducted using a radial-arm water maze. The time to reach platform significantly reduced after delivery of MCO1. Notably, the improvement in visually guided behavior was observed even at light intensity levels orders of magnitude lower than that required for Channelrhodopsin-2 opsin. Chronic light exposure study showed that chronic light exposure did not compromise viability of vMCO1-treated retina. Safe virus-mediated MCO1-delivery has potential for effective gene therapy of diverse retinal degenerations in patients.
机译:光退变性视网膜疾病,例如色素性视网膜炎(RP)和与干龄相关的黄斑变性(dry-AMD),导致数百万人失去视力。尽管光遗传疗法正在临床开发中,但是目前尚无手术或药物治疗方法。在这里,我们演示了在具有光变性视网膜的动物模型中使用多特征视蛋白(MCO1)进行视觉恢复。通过玻璃体内注射腺相关病毒可将MCO1可靠地递送至特定的视网膜细胞,从而显着改善了使用a臂水迷宫进行的视觉引导行为。交付MCO1后,到达平台的时间大大减少。值得注意的是,即使在比Channelrhodopsin-2视蛋白所需的光强度水平低几个数量级的情况下,也可以观察到视觉引导行为的改善。长期曝光研究表明,长期曝光不会损害vMCO1处理的视网膜的生存能力。安全的病毒介导的MCO1传递有潜力对患者的各种视网膜变性进行有效的基因治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号